Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.1.1.184: carbonyl reductase (NADPH)

This is an abbreviated version!
For detailed information about carbonyl reductase (NADPH), go to the full flat file.

Word Map on EC 1.1.1.184

Reaction

R-CHOH-R'
+
NADP+
=
R-CO-R'
+
NADPH
+
H+

Synonyms

(R) specific carbonyl reductase, (S)-specific carbonyl reductase, 15-hydroxyprostaglandin dehydrogenase [NADP+], 2,5-diketo-D-gluconic acid reductase, Adipocyte P27 protein, aldehyde reductase 1, aldehyde reductase I, aldo-keto reductase, ALR3, AP27, carbonyl reductase, carbonyl reductase (NADPH), carbonyl reductase 1, carbonyl reductase 3, carbonyl reductase S1, CBR, CBR 1, CBR 3, CBR1, CBR3, CHCR, CHCR1, CHCR2, CHCR3, CR, CR125, crc1, CSCR1, Gox0644, Gox1615, hCBR1, ketoreductase, KLCR1, KR, LCR, LOC415661, LOC610164, microsomal carbonyl reductase, More, NADP+-dependent ADH, NADPH-carbonyl reductase, NADPH-dependent carbonyl reductase, NADPH-dependent carbonyl reductase S1, NCCR, nonspecific NADPH-dependent carbonyl reductase, peroxisomal-type carbonyl reductase, PHCR, prostaglandin 9-ketoreductase, Prostaglandin-E2 9-reductase, PTCR, R-specific carbonyl reductase, reductase S1, reductase, carbonyl, RLCR, SCR, SCR9, SDR21C1, secondary-alcohol: NADP+-oxidoreductase, short-chain (S)-1-phenyl-1,2-ethanediol dehydrogenase, short-chain carbonyl reductase, sniffer, SRED, SSCR, SyS1, tetrameric carbonyl reductase, Tm1743, Tm_1743, xenobiotic carbonyl reductase, xenobiotic ketone reductase, YGL039w1, YGL039w2, YtbE, YueD

ECTree

     1 Oxidoreductases
         1.1 Acting on the CH-OH group of donors
             1.1.1 With NAD+ or NADP+ as acceptor
                1.1.1.184 carbonyl reductase (NADPH)

Inhibitors

Inhibitors on EC 1.1.1.184 - carbonyl reductase (NADPH)

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(2E)-1-(2,4-dihydroxyphenyl)-3-(2',4',6-trihydroxy-5'-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]biphenyl-3-yl)prop-2-en-1-one
-
1,10-phenanthroline
14,16-dihydroxy-3,8-dimethyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione
-
zearalenone analogue
18beta-glycyrrhetinic acid
-
inhibits the reduction of bupropion in liver microsomes
2,3,4-trinitrobenzenesulfonate sodium
-
acts on a catalytic lysine located at the cofactor binding site, rapid inactivation of the liver enzyme, kinetics, NADP+, 2'-AMP, 2',5'-ADP, and 2'-phospho-5'-ADP-ribose partly protect, but 4-acetylpyridine, 5'-AMP, 5'-ADP, NMN and NAD+ do not
2,3-Butanedione
-
irreversible inactivation
2,4-dinitrophenol
2,4-Dinitrophenylhydrazine
-
1mM, 0.9% residual activity
2-mercaptoethanol
2-nitrobenzoate
-
1mM, 8.6% residual activity
21-Hydroxy-5alpha-pregnane-3,20-dione
-
-
3',4',7-tris[O-(2-hydroxyethyl)]rutin
-
3,3-Tetramethyleneglutaric acid
-
enzyme form CR2 inhibited, CR1 slightly
3-(2-(2,4-dihydroxyphenyl)-1-[hydroxy(4-hydroxyphenyl)methyl]-2-oxoethyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
-
3-[2,3-dihydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-4H-chromen-4-one
-
3-[2-(2,4-dihydroxyphenyl)-1-(4-hydroxybenzyl)-2-oxoethyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
-
4-amino-1-tert-butyl-3-(2-hydroxyphenyl)pyrazolo[3,4-d]pyrimidine
-
4-hexanoylpyridine
-
competitive
4-hydroxymercuribenzoate
-
0.025 mM, complete inhibition
4-Methylpyrazole
-
2 mM, 17% inhibition
4-Oxo-4H-benzopyran-2-carboxylic acid
-
-
4-oxonon-2-enal
-
the substrate is also a mechanism-based inhibitor of the enzyme resulting in 50% inactivation of the enzyme-NADPH complex, presence of cofactor is required for inhibition
5,5 dithiobis(2-nitrobenzoate)
-
-
5beta-androstane-3alpha,17beta-diol
-
-
5beta-cholanoic acid
-
-
5beta-pregnane-3,20-dione
-
-
7-hydroxyethylrutoside
-
7-monohydroxyethylrutoside
inhibits the activity of CBR1 V88 and CBR1 I88 in a concentration-dependent manner. It acts as a competitive CBR1 inhibitor when using daunorubicin as a substrate and acts as an uncompetitive CBR1 inhibitor for the small quinone substrate menadione. It inhibits the binding of NADPH in an uncompetitive manner for both substrates
7-O-beta-D-glucopyranos2-ulosyl-quercetin
-
9,10-phenanthroline
-
strong inhibition
acetonitrile
-
37.7% residual activity at 5% (v/v)
Acetylsalicylate
-
IC50 for the 3 isozymes CHCR1-3, overview
AgNO3
Ammonium molybdate
-
enzyme form CR1 inhibited, CR2 not
androsterone
-
CR2 inhibited, CR1 not
ascorbic acid
-
1mM, 14% residual activity
Ba2+
-
92.24% residual activity at 1 mM
Barbital
Benzamide
Biochanin A
bromosulfophthalein
-
-
butyrophenone
-
inhibitory potency in decreasing order: hexanophenone, valerophenone, heptanophenone, butyrophenone, propiophenone
Ca2+
-
80.2% residual activity in the presence of Ca2+
chlorogenic acid
-
-
chlorpromazine
chrysin
-
-
cibacron
-
IC50 for the 3 isozymes CHCR1-3, overview
Cibacron blue
citrate
-
1mM, 48.3% residual activity
coumarin
-
-
CuCl2
-
only enzyme forms CR2, CR3
D-catechin
-
-
daidzein
71% residual activity at 0.05 mM
daidzin
74% residual activity at 0.05 mM
Dehydrolithocholic acid
-
-
dicoumarol
diethyldicarbonate
-
1mM, 32.8% residual activity
dimethyl sulfoxide
-
32.6% residual activity at 5% (v/v)
Diphenylhydantoin
-
68% inhibition at 0.5 mM
Disulfiram
dithiothreitol
Ethacrynic acid
ethanol
-
73.6% residual activity at 5% (v/v)
FeSO4
flavonoids
Flufenamic acid
-
-
Furosemide
-
inhibition of V1, V2 and T3
genistein
glycyrrhetinic acid
-
inhibits both 11beta-hydroxysteroid dehydrogenase and carbonyl reductase activities of the enzyme potently
heptanophenone
-
inhibitory potency in decreasing order: hexanophenone, valerophenone, heptanophenone, butyrophenone, propiophenone
hexanophenone
-
competitive. Inhibitory potency in decreasing order: hexanophenone, valerophenone, heptanophenone, butyrophenone, propiophenone
hydroxylamine
-
1mM, 29.5% residual activity
Hydroxyquinoline
-
1mM, 45% residual activity
indomethacin
iodoacetamide
-
46% inhibition at 1 mM
iodoacetate
Isobutyramide
-
-
Isopropanol
-
41.1% residual activity at 5% (v/v)
kaempferol
L-cysteine
-
1mM, 18.5% residual activity
lithocholic acid
-
-
megestrol acetate
-
IC50 for the 3 isozymes CHCR1-3, overview
menadione
Methyl vinyl ketone
-
74% inhibition at 10 mM
methyltestosterone
-
IC50 for the 3 isozymes CHCR1-3, overview
myristic acid
N-ethylmaleimide
NADP+
NADPH
-
competitive to NADH
naringenin
-
-
NEM
-
30% inhibition at 1 mM
nicotinic acid
-
weak
Norethindrone
-
IC50 for the 3 isozymes CHCR1-3, overview
o-phenanthroline
-
about 11% inhibition at 1 mM
oxalate
-
1mM, 42.8% residual activity
p-chloromercuribenzoate
p-hydroxymercuribenzoate
Pb2+
Candida macedoniensis
-
-
Phenylglyoxal
phenylpyruvic acid
-
-
PMSF
-
about 10% inhibition at 1 mM
progesterone
-
-
propiophenone
-
inhibitory potency in decreasing order: hexanophenone, valerophenone, heptanophenone, butyrophenone, propiophenone
pyrazole
Pyridine
-
19.8% residual activity at 5% (v/v)
pyruvate
-
inactivation of isozyme CHCR2, not of isozymes CHCR1 and 3
quercetin
quercitrin
Retin
-
-
-
rutin
S-nitrosoglutathione
Sn2+
Candida macedoniensis
-
-
sodium dodecylsulfate
0.1% w/v, complete loss of activity
Sodium phenobarbitone
-
enzyme form CR2 inhibited, CR1 slightly
testosterone
-
-
tetrahydrofuran
-
24.1% residual activity at 5% (v/v)
Tetramethyleneglutaric acid
-
-
triclosan
-
-
Triton X-100
1% v/v, 88% residual activity
valerophenone
-
inhibitory potency in decreasing order: hexanophenone, valerophenone, heptanophenone, butyrophenone, propiophenone
Valproic acid
-
-
warfarin
-
IC50 for the 3 isozymes CHCR1-3, overview
wedelolactone
-
-
additional information
-